Francis P. Tally

7.9k total citations
111 papers, 5.1k citations indexed

About

Francis P. Tally is a scholar working on Clinical Biochemistry, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Francis P. Tally has authored 111 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Clinical Biochemistry, 41 papers in Molecular Medicine and 38 papers in Infectious Diseases. Recurrent topics in Francis P. Tally's work include Bacterial Identification and Susceptibility Testing (55 papers), Antibiotic Resistance in Bacteria (41 papers) and Antibiotics Pharmacokinetics and Efficacy (29 papers). Francis P. Tally is often cited by papers focused on Bacterial Identification and Susceptibility Testing (55 papers), Antibiotic Resistance in Bacteria (41 papers) and Antibiotics Pharmacokinetics and Efficacy (29 papers). Francis P. Tally collaborates with scholars based in United States, China and Netherlands. Francis P. Tally's co-authors include N V Jacobus, Sherwood L. Gorbach, G J Cuchural, John G. Bartlett, S. L. Gorbach, B A Rasmussen, Judith N. Steenbergen, Jeff Alder, Grace M. Thorne and Vera L. Sutter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Annals of Internal Medicine and Clinical Infectious Diseases.

In The Last Decade

Francis P. Tally

111 papers receiving 4.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francis P. Tally United States 41 1.8k 1.6k 1.5k 1.3k 1.1k 111 5.1k
Michael Barza United States 49 1.3k 0.8× 732 0.4× 1.1k 0.7× 2.0k 1.5× 884 0.8× 182 7.6k
J. M. T. Hamilton‐Miller United Kingdom 39 2.0k 1.2× 923 0.6× 1.2k 0.8× 1.4k 1.1× 1.8k 1.7× 246 6.9k
Víctor Lorian United States 23 1.5k 0.8× 782 0.5× 1.5k 1.0× 1.4k 1.0× 1.1k 1.0× 108 5.4k
N V Jacobus United States 38 1.2k 0.7× 1.3k 0.8× 1.3k 0.9× 1.1k 0.8× 750 0.7× 75 3.7k
Jana M. Swenson United States 39 2.8k 1.6× 1.6k 1.0× 1.1k 0.7× 678 0.5× 942 0.9× 84 5.6k
W. Brumfitt United Kingdom 39 1.7k 1.0× 890 0.5× 923 0.6× 1.0k 0.8× 1.1k 1.0× 248 6.2k
Lowell S. Young United States 39 2.0k 1.1× 1.3k 0.8× 966 0.6× 1.1k 0.8× 616 0.6× 123 6.8k
S M Finegold United States 42 2.1k 1.2× 1.6k 1.0× 681 0.5× 562 0.4× 1.2k 1.1× 126 5.7k
J. F. Acar France 39 1.1k 0.6× 691 0.4× 1.9k 1.2× 1.3k 1.0× 630 0.6× 141 4.2k
Ethan Rubinstein Canada 45 2.4k 1.3× 877 0.5× 1.8k 1.2× 1.8k 1.3× 1.0k 1.0× 140 6.8k

Countries citing papers authored by Francis P. Tally

Since Specialization
Citations

This map shows the geographic impact of Francis P. Tally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis P. Tally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis P. Tally more than expected).

Fields of papers citing papers by Francis P. Tally

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis P. Tally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis P. Tally. The network helps show where Francis P. Tally may publish in the future.

Co-authorship network of co-authors of Francis P. Tally

This figure shows the co-authorship network connecting the top 25 collaborators of Francis P. Tally. A scholar is included among the top collaborators of Francis P. Tally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis P. Tally. Francis P. Tally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steenbergen, Judith N., Jeff Alder, Grace M. Thorne, & Francis P. Tally. (2005). Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections. Journal of Antimicrobial Chemotherapy. 55(3). 283–288. 422 indexed citations
2.
Oleson, Frederick B., Carol W. Berman, Jeannie B. Kirkpatrick, et al.. (2000). Once-Daily Dosing in Dogs Optimizes Daptomycin Safety. Antimicrobial Agents and Chemotherapy. 44(11). 2948–2953. 158 indexed citations
3.
Tally, Francis P.. (1999). Researchers reveal ways to defeat 'superbugs'. Drug Discovery Today. 4(9). 395–398. 6 indexed citations
4.
Sum, Phaik‐Eng, R. T. TESTA, Joseph J. Hlavka, et al.. (1994). ChemInform Abstract: Glycylcyclines. Part 1. A New Generation of Potent Antibacterial Agents Through Modification of 9‐Aminotetracyclines.. ChemInform. 25(17). 1 indexed citations
5.
Rasmussen, B A, Y Gluzman, & Francis P. Tally. (1991). Escherichia coli chromosomal mutations that permit direct cloning of the Bacteroides fragiiis metallo‐β‐lactamase gene, ccrA. Molecular Microbiology. 5(5). 1211–1219. 34 indexed citations
6.
Rasmussen, B A, H F Noller, Gary Daubresse, et al.. (1991). Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrobial Agents and Chemotherapy. 35(11). 2306–2311. 76 indexed citations
7.
Watanabe, Kunitomo, et al.. (1990). R-plasmid mediated transfer of .BETA.-lactam resistance in Bacteroides fragilis.. The Journal of Antibiotics. 43(10). 1302–1306. 7 indexed citations
8.
Cuchural, G J, et al.. (1988). Permeability to β-lactams in Bacteroides fragilis. Journal of Antimicrobial Chemotherapy. 22(6). 785–790. 16 indexed citations
9.
Malamy, Michael H., et al.. (1987). Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation. Antimicrobial Agents and Chemotherapy. 31(11). 1739–1743. 17 indexed citations
10.
Cuchural, G J, et al.. (1986). Beta-lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrobial Agents and Chemotherapy. 30(5). 645–648. 135 indexed citations
11.
Tally, Francis P., et al.. (1982). Synthesis of 1-(2-hydroxyethyl)-2-methyl-5-aminoimidazole: a ring-intact reduction product of metronidazole. Biochemical Pharmacology. 31(16). 2689–2691. 20 indexed citations
12.
Cuchural, G J & Francis P. Tally. (1982). Factors affecting the choice of antimicrobial therapy for anaerobic infection. Journal of Antimicrobial Chemotherapy. 10(suppl A). 11–22. 8 indexed citations
13.
Tally, Francis P., et al.. (1982). Bacteroides fragilis resistance to clindamycin in vitro. Antimicrobial Agents and Chemotherapy. 22(5). 771–774. 15 indexed citations
14.
Tally, Francis P., Katherine McGowan, John M. Kellum, Sherwood L. Gorbach, & Thomas F. O’Donnell. (1981). A Randomized Comparison of Cefoxitin with or without Amikacin and Clindamycin plus Amikacin in Surgical Sepsis. Annals of Surgery. 193(3). 318–323. 97 indexed citations
15.
Teele, David W., Gerald B. Healy, & Francis P. Tally. (1980). Persistent Effusions of the Middle Ear. Annals of Otology Rhinology & Laryngology. 89(3_suppl). 102–103. 10 indexed citations
16.
Tally, Francis P., N V Jacobus, & Sherwood L. Gorbach. (1978). In Vitro Activity of Thienamycin. Antimicrobial Agents and Chemotherapy. 14(3). 436–438. 58 indexed citations
17.
Tally, Francis P., N V Jacobus, John G. Bartlett, & Sherwood L. Gorbach. (1975). In Vitro Activity of Penicillins Against Anaerobes. Antimicrobial Agents and Chemotherapy. 7(4). 413–414. 22 indexed citations
18.
Tally, Francis P., Phyllis Stewart, Vera L. Sutter, & Jon E. Rosenblatt. (1975). Oxygen tolerance of fresh clinical anaerobic bacteria. Journal of Clinical Microbiology. 1(2). 161–164. 116 indexed citations
19.
Tally, Francis P., N V Jacobus, John G. Bartlett, & Sherwood L. Gorbach. (1975). Susceptibility of Anaerobes to Cefoxitin and Other Cephalosporins. Antimicrobial Agents and Chemotherapy. 7(2). 128–132. 118 indexed citations
20.
Tally, Francis P., et al.. (1974). Susceptibility of Clostridium ramosum to Antimicrobial Agents. Antimicrobial Agents and Chemotherapy. 5(6). 589–593. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Barza Breakdown of academic impact, for papers by J. M. T. Hamilton‐Miller Breakdown of academic impact, for papers by Víctor Lorian Breakdown of academic impact, for papers by N V Jacobus Breakdown of academic impact, for papers by Jana M. Swenson Breakdown of academic impact, for papers by W. Brumfitt Breakdown of academic impact, for papers by Lowell S. Young Breakdown of academic impact, for papers by S M Finegold Breakdown of academic impact, for papers by J. F. Acar Breakdown of academic impact, for papers by Ethan Rubinstein
Rankless by CCL
2026